<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01692821</url>
  </required_header>
  <id_info>
    <org_study_id>OPHT-180312</org_study_id>
    <nct_id>NCT01692821</nct_id>
  </id_info>
  <brief_title>Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation</brief_title>
  <official_title>Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate perfusion and oxygenation is essential for the function of the inner retina.&#xD;
      Although it is known that oxygen tension is very well autoregulated in the retina, the&#xD;
      physiological mechanisms behind this regulation process are not fully explored. The&#xD;
      development of new instruments for the non-invasive measurement of oxygen tension in retinal&#xD;
      vessels now allows for the more precise investigation of these physiological processes. The&#xD;
      current study seeks to evaluate the retinal oxygen saturation in healthy subjects while&#xD;
      breathing different oxygen mixtures to achieve a hypoxic and a hyperoxic state.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retinal oxygen saturation</measure>
    <time_frame>On the study day - during each breathing period (6 times)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinal blood flow</measure>
    <time_frame>On the study day - during each breathing period (6 times)</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Retinal Oxygenation</condition>
  <condition>Retinal Blood Flow</condition>
  <arm_group>
    <arm_group_label>100% oxygen breathing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>15% oxygen in N2 breathing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>12% oxygen in N2 breathing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>100% oxygen breathing</intervention_name>
    <description>100% oxygen breathing - 30 minutes</description>
    <arm_group_label>100% oxygen breathing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>15% oxygen in N2 breathing</intervention_name>
    <description>15% oxygen in N2 breathing - 30 minutes</description>
    <arm_group_label>15% oxygen in N2 breathing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>12% oxygen in N2 breathing</intervention_name>
    <description>12% oxygen in N2 breathing - 30 minutes</description>
    <arm_group_label>12% oxygen in N2 breathing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women aged between 18 and 35 years&#xD;
&#xD;
          -  Nonsmokers&#xD;
&#xD;
          -  Normal findings in the medical history and physical examination unless the&#xD;
             investigator considers an abnormality to be clinically irrelevant&#xD;
&#xD;
          -  Normal laboratory values unless the investigator considers an abnormality to be&#xD;
             clinically irrelevant&#xD;
&#xD;
          -  Normal ophthalmic findings, ametropy &lt; 3 Dpt.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Regular use of medication, abuse of alcoholic beverages, participation in a clinical&#xD;
             trial in the 3 weeks preceding the study (except oral contraceptive)&#xD;
&#xD;
          -  Symptoms of a clinically relevant illness in the 3 weeks before the first study day&#xD;
&#xD;
          -  Presence of any form of anemia&#xD;
&#xD;
          -  Blood donation during the previous 3 weeks&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Garh√∂fer, Assoc. Prof. Priv.-Doz. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Pharmacology, Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna, Department of Clinical Pharmacology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>June 14, 2012</study_first_submitted>
  <study_first_submitted_qc>September 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2012</study_first_posted>
  <last_update_submitted>January 29, 2013</last_update_submitted>
  <last_update_submitted_qc>January 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerhard Garhofer</investigator_full_name>
    <investigator_title>Assoc. Prof. Priv.-Doz. Dr.</investigator_title>
  </responsible_party>
  <keyword>retinal oxygen saturation</keyword>
  <keyword>retinal blood flow</keyword>
  <keyword>hyperoxia</keyword>
  <keyword>hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Hyperoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

